DNLI
Denali TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
DNLI vs peer average
56/100
DNLI vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
BEAM is the first available peer comparator.
Similar-sized biopharma where valuation is driven by platform validation, clinical readouts, and financing/runway confidence rather than near-term steady-state earnings.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DNLI
Denali Therapeutics
BEAM
Beam Therapeutics
Grade
C
A
Momentum
27
19
Value
41
41
Sentiment
73
95
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs BEAM
DNLI / BEAM
Grade Position
In line
DNLI vs. peer average (C vs. C)
56/100
Momentum
27
DNLIValue
41
DNLISentiment
73
BEAMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DNLI
BEAM is the first peer returned for this comparison set.